Michael Ehlers
Neuroscience Chief Scientific Officer
Pfizer
From this contributor
A cautionary tale for autism drug development
Poorly designed animal drug studies for motor disorders have led to spurious conclusions for the clinical trials that follow. This may be even more true for autism research, says Michael Ehlers.
SHANK mutations converge at neuronal junctions in autism
SHANK3, one of the strongest candidate genes for autism, has the potential to be a molecular entry point into understanding the synaptic, developmental and circuit origins of the disorder.
SHANK mutations converge at neuronal junctions in autism
Drug zone
Rodent and stem cell models remain challenging for developing psychiatric drugs, says Michael Ehlers, chief scientific officer of neuroscience at Pfizer.
Explore more from The Transmitter
Brain registers spatial location outside hippocampus
A more complex picture of how an animal’s brain tracks its location is starting to emerge.
Brain registers spatial location outside hippocampus
A more complex picture of how an animal’s brain tracks its location is starting to emerge.
The three-banded panther worm is rewriting the story of brain evolution
The animal has a brain structure all its own, according to a 2026 preprint. The finding hints that brains could have evolved centralization before regionalization.
The three-banded panther worm is rewriting the story of brain evolution
The animal has a brain structure all its own, according to a 2026 preprint. The finding hints that brains could have evolved centralization before regionalization.
Does cognition happen in brain areas or between them?
Michael Cole explains how "brain flows" are the fundamental units of brain function and cognition.
Does cognition happen in brain areas or between them?
Michael Cole explains how "brain flows" are the fundamental units of brain function and cognition.